Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
2
×
boston blog main
boston top stories
clinical trials
drugs
2
×
fda
life sciences
national blog main
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
2
×
san francisco top stories
akcea therapeutics
alnylam pharmaceuticals
antibiotics
arvinas
astrazeneca
barry greene
boston university
boulder/denver
boulder/denver blog main
boulder/denver top stories
carbapenem-resistant enterobacteriaceae
celgene
dan ollendorf
detroit
detroit blog main
detroit top stories
entasis therapeutics
gritstone oncology
guardant health
hereditary transthyretin amyloidosis
indiana
indiana blog main
indiana top stories
inotersen
What
ago
alnylam
approve
awaits
biological
biotechs
chose
close
company
crossed
decades
decision
device
discovered
fda
fingers
firms
friday
historic
ipo
ipos
life
make
medical
medicine
open
patients
q
quarter
rna
science
time
trick
uses
way
week
window
Language
Current search:
drugs
×
boston
×
" san francisco blog main "
×
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision